CVS (CVS Health Corporation) Stock Financials & Earnings

CVSCVS Health Corporation

Mkt Cap$99B

Revenue (TTM)$402.1B

Net Income (TTM)$1.8B

EPS (TTM)$1.38

Free Cash Flow (TTM)$7.8B

Gross Margin13.8%

Op. Margin1.2%

Net Margin0.4%

FCF Margin1.9%

P/S Ratio (TTM)0.2x

P/E Ratio (TTM)56.0x

YoY Rev Growth+7.8%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$85.3B	$13.4B	$3.4B
Q2 23	$88.9B	$13.6B	$3.2B
Q3 23	$89.8B	$13.6B	$3.7B
Q4 23	$93.8B	$13.9B	$3.4B
Q1 24	$88.4B	$12.6B	$2.3B
Q2 24	$91.2B	$13.4B	$3.0B
Q3 24	$95.4B	$12.6B	$832M
Q4 24	$97.7B	$12.9B	$2.4B
Q1 25	$94.6B	$14.4B	$3.4B
Q2 25	$98.9B	$13.6B	$2.4B
Q3 25	$102.9B	$13.8B	-$3.2B
Q4 25	$105.7B	$13.6B	$2.1B

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

Revenue Segments

Quarter	Front Store Revenue	Pharmacy Revenue	Premiums	Product and Service, Other	Corporate And Other Segment
Q1 23	$5.6B	$52.5B	$24.4B	$2.5B	—
Q2 23	$5.6B	$55.1B	$25.1B	$2.8B	—
Q3 23	$5.4B	$56.2B	$24.7B	$3.3B	—
Q4 23	$5.9B	$59.7B	$25.1B	$2.9B	—
Q1 24	$5.4B	$48.4B	$30.4B	$3.8B	—
Q2 24	$5.3B	$51.0B	$30.7B	$3.9B	—
Q3 24	$5.2B	$54.7B	$30.9B	$4.1B	—
Q4 24	$5.7B	$56.2B	$30.9B	$4.1B	—
Q1 25	$5.2B	$52.5B	$32.8B	$3.5B	—
Q2 25	$5.4B	$55.3B	$34.2B	$3.5B	$96M
Q3 25	$5.2B	$59.5B	$33.7B	$1.0B	—
Q4 25	$5.7B	$61.6B	$34.0B	—	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$14.6B	$3.1B	$17.7B
Q2 23	$13.8B	$3.1B	$16.9B
Q3 23	$13.0B	$3.1B	$16.2B
Q4 23	$8.2B	$3.3B	$11.5B
Q1 24	$9.8B	$3.3B	$13.1B
Q2 24	$12.5B	$3.8B	$16.3B
Q3 24	$6.9B	$2.8B	$9.7B
Q4 24	$8.6B	$2.4B	$11.0B
Q1 25	$10.1B	$2.6B	$12.7B
Q2 25	$11.8B	$2.4B	$14.2B
Q3 25	$9.2B	$2.1B	$11.3B
Q4 25	$8.5B	$2.1B	$10.7B

Shares Outstanding

Revenue Per Employee

Revenue / Employee